Congratulations to Brian Fury, our GMP Facility Director at UC Davis Health @ucdavis.bsky.social, and to all of the other recipients of these G-Rex grant awards from ScaleReady.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight...
www.prnewswire.com
September 12, 2025 at 5:18 PM
Congratulations to Brian Fury, our GMP Facility Director at UC Davis Health @ucdavis.bsky.social, and to all of the other recipients of these G-Rex grant awards from ScaleReady.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
Congratulations to Dr. Dawn Ward of the UCLA Human Gene and Cell Therapy Facility for receiving a G-Rex Grant that will support production of a novel iNKT cell therapy developed by Dr. Lili Yang! 🦠🧪🧫
🔗 bit.ly/46bUIso
#ResearchPowersProgress
🔗 bit.ly/46bUIso
#ResearchPowersProgress
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight...
bit.ly
September 12, 2025 at 12:28 AM
Congratulations to Dr. Dawn Ward of the UCLA Human Gene and Cell Therapy Facility for receiving a G-Rex Grant that will support production of a novel iNKT cell therapy developed by Dr. Lili Yang! 🦠🧪🧫
🔗 bit.ly/46bUIso
#ResearchPowersProgress
🔗 bit.ly/46bUIso
#ResearchPowersProgress
ScaleReady Awards $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. for Innovative Cancer Therapy Development#USA#G-Rex_Grant#St._Paul#A2_Biotherapeutics#CellReady
ScaleReady Awards $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. for Innovative Cancer Therapy Development
ScaleReady has awarded a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc., enhancing their capabilities in developing CAR-T cell therapies.
third-news.com
May 6, 2025 at 11:22 AM
ScaleReady Awards $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. for Innovative Cancer Therapy Development#USA#G-Rex_Grant#St._Paul#A2_Biotherapeutics#CellReady
CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis - bioinformant.com/chu-toulouse...
CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis | BioInformant
Toulouse, January 22, 2026 — Cell-Easy, a CDMO specialized in the development and GMP manufacturing of Advanced Therapy Medicinal Products (ATMPs), announces a new clinical milestone achieved in close...
bioinformant.com
January 22, 2026 at 8:14 PM
CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis - bioinformant.com/chu-toulouse...
CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease - bioinformant.com/chu-toulouse...
CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease | BioInformant
Cell-Easy, a Contract Development and Manufacturing Organization (CDMO) specialized in advanced cell therapies, announces that its allogeneic adipose-derived mesenchymal stem cell product, CellReady®,...
bioinformant.com
May 28, 2025 at 1:25 AM
CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease - bioinformant.com/chu-toulouse...
Thoughts on this? >> ScaleReady Announces Award of a G-Rex® Grant to the Gates
Institute’s Translational Sciences Laboratory >> Comment below! #industry40 #AI #healthtech #mhealth #IoT
Institute’s Translational Sciences Laboratory >> Comment below! #industry40 #AI #healthtech #mhealth #IoT
ScaleReady Announces Award of a G-Rex® Grant to the Gates
Institute’s Translational Sciences Laboratory
ST. PAUL, Minn., Aug. 14, 2025 /PRNewswire/ — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that the Translational Sciences Laboratory at Gates Institute, a leading contract development and manufacturing organization (CDMO) based at the University of Colorado Anschutz Medical Campus, has been awarded a $300,000 G-Rex® Grant to develop …
dlvr.it
August 14, 2025 at 11:47 AM
Thoughts on this? >> ScaleReady Announces Award of a G-Rex® Grant to the Gates
Institute’s Translational Sciences Laboratory >> Comment below! #industry40 #AI #healthtech #mhealth #IoT
Institute’s Translational Sciences Laboratory >> Comment below! #industry40 #AI #healthtech #mhealth #IoT